Company intelligence / Profile preview

Canlac

Victoriaville, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

Canlac is a major global producer of pharmaceutical-grade lactulose, a synthetic disaccharide used extensively in the treatment of constipation and hepatic encephalopathy. Based in Victoriaville, Quebec, the company operates a large-scale manufacturing facility that specializes in the processing of lactose-derived ingredients. Canlac was acquired by the Irish global nutrition group Glanbia in 2005 and now functions as a key production site within the Glanbia Nutritionals division. The company is recognized for its high-purity manufacturing standards, adhering to Good Manufacturing Practices (GMP) to supply the international pharmaceutical and food industries.

Therapeutic areas: Gastroenterology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Canlac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canlac.

Explore the full profile